nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC22A1—hematologic cancer	0.219	1	CbGaD
Norepinephrine—L-DOPA—Melphalan—hematologic cancer	0.175	1	CrCrCtD
Norepinephrine—SLC22A3—Melphalan—hematologic cancer	0.066	0.173	CbGbCtD
Norepinephrine—SLC22A2—Daunorubicin—hematologic cancer	0.0276	0.0724	CbGbCtD
Norepinephrine—SLC22A2—Cytarabine—hematologic cancer	0.0244	0.0639	CbGbCtD
Norepinephrine—SLC22A2—Cladribine—hematologic cancer	0.023	0.0603	CbGbCtD
Norepinephrine—SLC22A3—Irinotecan—hematologic cancer	0.0223	0.0585	CbGbCtD
Norepinephrine—SLC22A1—Cytarabine—hematologic cancer	0.0212	0.0555	CbGbCtD
Norepinephrine—SLC22A2—Imatinib—hematologic cancer	0.0212	0.0555	CbGbCtD
Norepinephrine—CYP1A2—Anagrelide—hematologic cancer	0.0207	0.0543	CbGbCtD
Norepinephrine—SLC22A1—Cladribine—hematologic cancer	0.02	0.0524	CbGbCtD
Norepinephrine—SLC22A3—Vincristine—hematologic cancer	0.0195	0.0512	CbGbCtD
Norepinephrine—SLC22A1—Imatinib—hematologic cancer	0.0184	0.0482	CbGbCtD
Norepinephrine—SLC22A2—Vinblastine—hematologic cancer	0.0118	0.0308	CbGbCtD
Norepinephrine—CYP1A2—Carmustine—hematologic cancer	0.0109	0.0285	CbGbCtD
Norepinephrine—SLC22A2—Cisplatin—hematologic cancer	0.0108	0.0283	CbGbCtD
Norepinephrine—CYP1A2—Methoxsalen—hematologic cancer	0.00924	0.0242	CbGbCtD
Norepinephrine—CYP1A2—Bortezomib—hematologic cancer	0.00879	0.0231	CbGbCtD
Norepinephrine—CYP1A2—Daunorubicin—hematologic cancer	0.00841	0.022	CbGbCtD
Norepinephrine—CYP1A2—Alitretinoin—hematologic cancer	0.00824	0.0216	CbGbCtD
Norepinephrine—CYP1A2—Thalidomide—hematologic cancer	0.00766	0.0201	CbGbCtD
Norepinephrine—CYP1A2—Dacarbazine—hematologic cancer	0.00659	0.0173	CbGbCtD
Norepinephrine—CYP1A2—Imatinib—hematologic cancer	0.00644	0.0169	CbGbCtD
Norepinephrine—CYP1A2—Dasatinib—hematologic cancer	0.00517	0.0136	CbGbCtD
Norepinephrine—CYP1A2—Etoposide—hematologic cancer	0.00322	0.00845	CbGbCtD
Norepinephrine—PAH—hematopoietic system—hematologic cancer	0.00209	0.115	CbGeAlD
Norepinephrine—L-DOPA—PSIP1—hematologic cancer	0.0016	0.519	CrCbGaD
Norepinephrine—PAH—blood—hematologic cancer	0.00139	0.0765	CbGeAlD
Norepinephrine—SLC18A1—lymph node—hematologic cancer	0.00116	0.0639	CbGeAlD
Norepinephrine—Isoprenaline—PIK3R1—hematologic cancer	0.000991	0.322	CrCbGaD
Norepinephrine—SLC18A2—hematopoietic system—hematologic cancer	0.000931	0.0514	CbGeAlD
Norepinephrine—SLC22A3—hematopoietic system—hematologic cancer	0.000663	0.0366	CbGeAlD
Norepinephrine—SLC18A2—blood—hematologic cancer	0.000617	0.0341	CbGeAlD
Norepinephrine—SLC18A2—lung—hematologic cancer	0.00054	0.0299	CbGeAlD
Norepinephrine—ADRA1A—hematopoietic system—hematologic cancer	0.000528	0.0292	CbGeAlD
Norepinephrine—SLC18A2—testis—hematologic cancer	0.00051	0.0282	CbGeAlD
Norepinephrine—SLC22A3—gonad—hematologic cancer	0.000504	0.0278	CbGeAlD
Norepinephrine—SLC22A1—blood—hematologic cancer	0.000459	0.0254	CbGeAlD
Norepinephrine—CYP1A2—hematopoietic system—hematologic cancer	0.000437	0.0241	CbGeAlD
Norepinephrine—SLC6A2—gonad—hematologic cancer	0.000432	0.0238	CbGeAlD
Norepinephrine—ADRA2A—hematopoietic system—hematologic cancer	0.000401	0.0222	CbGeAlD
Norepinephrine—ADRB1—lung—hematologic cancer	0.000388	0.0214	CbGeAlD
Norepinephrine—SLC22A3—lung—hematologic cancer	0.000385	0.0213	CbGeAlD
Norepinephrine—SLC18A2—lymph node—hematologic cancer	0.00037	0.0204	CbGeAlD
Norepinephrine—SLC22A3—testis—hematologic cancer	0.000363	0.0201	CbGeAlD
Norepinephrine—ADRA1A—blood—hematologic cancer	0.00035	0.0193	CbGeAlD
Norepinephrine—ADRA2C—blood—hematologic cancer	0.000333	0.0184	CbGeAlD
Norepinephrine—SLC6A2—lung—hematologic cancer	0.00033	0.0182	CbGeAlD
Norepinephrine—SLC22A5—blood—hematologic cancer	0.000319	0.0176	CbGeAlD
Norepinephrine—SLC6A2—testis—hematologic cancer	0.000311	0.0172	CbGeAlD
Norepinephrine—ADRA2A—gonad—hematologic cancer	0.000305	0.0169	CbGeAlD
Norepinephrine—DRD2—lung—hematologic cancer	0.000301	0.0166	CbGeAlD
Norepinephrine—ADRA2C—lung—hematologic cancer	0.000292	0.0161	CbGeAlD
Norepinephrine—CYP1A2—blood—hematologic cancer	0.000289	0.016	CbGeAlD
Norepinephrine—DRD2—testis—hematologic cancer	0.000284	0.0157	CbGeAlD
Norepinephrine—SLC22A5—lung—hematologic cancer	0.00028	0.0155	CbGeAlD
Norepinephrine—ADRA2C—testis—hematologic cancer	0.000276	0.0152	CbGeAlD
Norepinephrine—Anxiety—Busulfan—hematologic cancer	0.000272	0.00277	CcSEcCtD
Norepinephrine—Dyspnoea—Clofarabine—hematologic cancer	0.000269	0.00274	CcSEcCtD
Norepinephrine—Dyspnoea—Daunorubicin—hematologic cancer	0.000269	0.00274	CcSEcCtD
Norepinephrine—Hypertension—Procarbazine—hematologic cancer	0.000268	0.00273	CcSEcCtD
Norepinephrine—Dyspnoea—Pentostatin—hematologic cancer	0.000268	0.00273	CcSEcCtD
Norepinephrine—Dyspnoea—Anagrelide—hematologic cancer	0.000268	0.00273	CcSEcCtD
Norepinephrine—ADRA2A—blood—hematologic cancer	0.000266	0.0147	CbGeAlD
Norepinephrine—SLC22A5—testis—hematologic cancer	0.000264	0.0146	CbGeAlD
Norepinephrine—Anxiety—Procarbazine—hematologic cancer	0.000264	0.00269	CcSEcCtD
Norepinephrine—SLC22A3—lymph node—hematologic cancer	0.000263	0.0145	CbGeAlD
Norepinephrine—Hypertension—Bexarotene—hematologic cancer	0.000263	0.00268	CcSEcCtD
Norepinephrine—Hypertension—Dasatinib—hematologic cancer	0.000263	0.00268	CcSEcCtD
Norepinephrine—Bradycardia—Bortezomib—hematologic cancer	0.000263	0.00267	CcSEcCtD
Norepinephrine—Chest pain—Dasatinib—hematologic cancer	0.000259	0.00264	CcSEcCtD
Norepinephrine—Chest pain—Bexarotene—hematologic cancer	0.000259	0.00264	CcSEcCtD
Norepinephrine—Anxiety—Dasatinib—hematologic cancer	0.000259	0.00263	CcSEcCtD
Norepinephrine—Anxiety—Bexarotene—hematologic cancer	0.000259	0.00263	CcSEcCtD
Norepinephrine—Arrhythmia—Melphalan—hematologic cancer	0.000258	0.00262	CcSEcCtD
Norepinephrine—Vomiting—Lomustine—hematologic cancer	0.000254	0.00259	CcSEcCtD
Norepinephrine—CYP1A2—lung—hematologic cancer	0.000254	0.014	CbGeAlD
Norepinephrine—Dyspnoea—Teniposide—hematologic cancer	0.000252	0.00256	CcSEcCtD
Norepinephrine—Arrhythmia—Lenalidomide—hematologic cancer	0.00025	0.00255	CcSEcCtD
Norepinephrine—Sweating—Thalidomide—hematologic cancer	0.000248	0.00253	CcSEcCtD
Norepinephrine—Hyperhidrosis—Procarbazine—hematologic cancer	0.000245	0.0025	CcSEcCtD
Norepinephrine—Vomiting—Mechlorethamine—hematologic cancer	0.000243	0.00248	CcSEcCtD
Norepinephrine—Hypertension—Nilotinib—hematologic cancer	0.000243	0.00248	CcSEcCtD
Norepinephrine—Hypertension—Imatinib—hematologic cancer	0.000242	0.00246	CcSEcCtD
Norepinephrine—Hyperhidrosis—Bexarotene—hematologic cancer	0.00024	0.00245	CcSEcCtD
Norepinephrine—Hyperhidrosis—Dasatinib—hematologic cancer	0.00024	0.00245	CcSEcCtD
Norepinephrine—Hyperhidrosis—Fludarabine—hematologic cancer	0.00024	0.00244	CcSEcCtD
Norepinephrine—Chest pain—Nilotinib—hematologic cancer	0.00024	0.00244	CcSEcCtD
Norepinephrine—Anxiety—Nilotinib—hematologic cancer	0.000239	0.00243	CcSEcCtD
Norepinephrine—Chest pain—Imatinib—hematologic cancer	0.000238	0.00243	CcSEcCtD
Norepinephrine—Anxiety—Imatinib—hematologic cancer	0.000238	0.00242	CcSEcCtD
Norepinephrine—Bradycardia—Thalidomide—hematologic cancer	0.000237	0.00241	CcSEcCtD
Norepinephrine—Sweating—Alitretinoin—hematologic cancer	0.000236	0.00241	CcSEcCtD
Norepinephrine—Extravasation—Methotrexate—hematologic cancer	0.000236	0.00241	CcSEcCtD
Norepinephrine—Chest pain—Cladribine—hematologic cancer	0.000234	0.00239	CcSEcCtD
Norepinephrine—Anxiety—Cladribine—hematologic cancer	0.000233	0.00238	CcSEcCtD
Norepinephrine—Dyspnoea—Busulfan—hematologic cancer	0.000233	0.00237	CcSEcCtD
Norepinephrine—ADRA2A—lung—hematologic cancer	0.000233	0.0129	CbGeAlD
Norepinephrine—Arrhythmia—Bortezomib—hematologic cancer	0.00023	0.00235	CcSEcCtD
Norepinephrine—Hypertension—Vinblastine—hematologic cancer	0.000228	0.00232	CcSEcCtD
Norepinephrine—Sweating—Vincristine—hematologic cancer	0.000228	0.00232	CcSEcCtD
Norepinephrine—SLC6A2—lymph node—hematologic cancer	0.000226	0.0125	CbGeAlD
Norepinephrine—Arrhythmia—Vinorelbine—hematologic cancer	0.000225	0.00229	CcSEcCtD
Norepinephrine—Bradycardia—Ifosfamide—hematologic cancer	0.000223	0.00227	CcSEcCtD
Norepinephrine—Hyperhidrosis—Nilotinib—hematologic cancer	0.000222	0.00226	CcSEcCtD
Norepinephrine—Sweating—Mitoxantrone—hematologic cancer	0.000222	0.00226	CcSEcCtD
Norepinephrine—Sweating—Irinotecan—hematologic cancer	0.000222	0.00226	CcSEcCtD
Norepinephrine—Dyspnoea—Bexarotene—hematologic cancer	0.000222	0.00226	CcSEcCtD
Norepinephrine—Dyspnoea—Dasatinib—hematologic cancer	0.000222	0.00226	CcSEcCtD
Norepinephrine—Dyspnoea—Fludarabine—hematologic cancer	0.000221	0.00225	CcSEcCtD
Norepinephrine—Extravasation—Epirubicin—hematologic cancer	0.000221	0.00225	CcSEcCtD
Norepinephrine—Hyperhidrosis—Imatinib—hematologic cancer	0.000221	0.00225	CcSEcCtD
Norepinephrine—ADRA2A—testis—hematologic cancer	0.00022	0.0122	CbGeAlD
Norepinephrine—Hyperhidrosis—Cladribine—hematologic cancer	0.000217	0.00221	CcSEcCtD
Norepinephrine—Sweating—Gemcitabine—hematologic cancer	0.000216	0.0022	CcSEcCtD
Norepinephrine—Arrhythmia—Thiotepa—hematologic cancer	0.000215	0.00219	CcSEcCtD
Norepinephrine—Chest pain—Melphalan—hematologic cancer	0.000214	0.00218	CcSEcCtD
Norepinephrine—Bradycardia—Mitoxantrone—hematologic cancer	0.000211	0.00215	CcSEcCtD
Norepinephrine—Bradycardia—Irinotecan—hematologic cancer	0.000211	0.00215	CcSEcCtD
Norepinephrine—Hypertension—Lenalidomide—hematologic cancer	0.000211	0.00215	CcSEcCtD
Norepinephrine—Arrhythmia—Thalidomide—hematologic cancer	0.000208	0.00212	CcSEcCtD
Norepinephrine—Chest pain—Lenalidomide—hematologic cancer	0.000208	0.00212	CcSEcCtD
Norepinephrine—Anxiety—Lenalidomide—hematologic cancer	0.000207	0.00211	CcSEcCtD
Norepinephrine—Vomiting—Nelarabine—hematologic cancer	0.000205	0.00209	CcSEcCtD
Norepinephrine—Dyspnoea—Nilotinib—hematologic cancer	0.000205	0.00209	CcSEcCtD
Norepinephrine—Extravasation—Doxorubicin—hematologic cancer	0.000205	0.00208	CcSEcCtD
Norepinephrine—Dyspnoea—Imatinib—hematologic cancer	0.000204	0.00207	CcSEcCtD
Norepinephrine—Headache—Nelarabine—hematologic cancer	0.000202	0.00206	CcSEcCtD
Norepinephrine—Dyspnoea—Cladribine—hematologic cancer	0.0002	0.00204	CcSEcCtD
Norepinephrine—ADRA2C—lymph node—hematologic cancer	0.0002	0.011	CbGeAlD
Norepinephrine—Arrhythmia—Carmustine—hematologic cancer	0.0002	0.00203	CcSEcCtD
Norepinephrine—Arrhythmia—Alitretinoin—hematologic cancer	0.000198	0.00201	CcSEcCtD
Norepinephrine—Headache—Methoxsalen—hematologic cancer	0.000198	0.00201	CcSEcCtD
Norepinephrine—Arrhythmia—Ifosfamide—hematologic cancer	0.000195	0.00199	CcSEcCtD
Norepinephrine—Vomiting—Mercaptopurine—hematologic cancer	0.000195	0.00198	CcSEcCtD
Norepinephrine—Hypertension—Bortezomib—hematologic cancer	0.000194	0.00197	CcSEcCtD
Norepinephrine—Hyperhidrosis—Lenalidomide—hematologic cancer	0.000193	0.00196	CcSEcCtD
Norepinephrine—Vomiting—Clofarabine—hematologic cancer	0.000192	0.00196	CcSEcCtD
Norepinephrine—Vomiting—Daunorubicin—hematologic cancer	0.000192	0.00196	CcSEcCtD
Norepinephrine—Bradycardia—Cisplatin—hematologic cancer	0.000192	0.00196	CcSEcCtD
Norepinephrine—SLC22A5—lymph node—hematologic cancer	0.000191	0.0106	CbGeAlD
Norepinephrine—Vomiting—Anagrelide—hematologic cancer	0.000191	0.00195	CcSEcCtD
Norepinephrine—Vomiting—Pentostatin—hematologic cancer	0.000191	0.00195	CcSEcCtD
Norepinephrine—Chest pain—Bortezomib—hematologic cancer	0.000191	0.00195	CcSEcCtD
Norepinephrine—Anxiety—Bortezomib—hematologic cancer	0.000191	0.00194	CcSEcCtD
Norepinephrine—Chest pain—Bleomycin—hematologic cancer	0.00019	0.00193	CcSEcCtD
Norepinephrine—Headache—Daunorubicin—hematologic cancer	0.000189	0.00193	CcSEcCtD
Norepinephrine—Headache—Clofarabine—hematologic cancer	0.000189	0.00193	CcSEcCtD
Norepinephrine—Hypertension—Vinorelbine—hematologic cancer	0.000189	0.00193	CcSEcCtD
Norepinephrine—Headache—Pentostatin—hematologic cancer	0.000188	0.00192	CcSEcCtD
Norepinephrine—Headache—Anagrelide—hematologic cancer	0.000188	0.00192	CcSEcCtD
Norepinephrine—Chest pain—Vinorelbine—hematologic cancer	0.000187	0.0019	CcSEcCtD
Norepinephrine—Arrhythmia—Irinotecan—hematologic cancer	0.000186	0.00189	CcSEcCtD
Norepinephrine—Arrhythmia—Mitoxantrone—hematologic cancer	0.000186	0.00189	CcSEcCtD
Norepinephrine—Vomiting—Idarubicin—hematologic cancer	0.000184	0.00188	CcSEcCtD
Norepinephrine—Dopamine—SLC22A1—hematologic cancer	0.000184	0.0596	CrCbGaD
Norepinephrine—Dyspnoea—Melphalan—hematologic cancer	0.000183	0.00186	CcSEcCtD
Norepinephrine—Headache—Idarubicin—hematologic cancer	0.000182	0.00185	CcSEcCtD
Norepinephrine—Hypertension—Thiotepa—hematologic cancer	0.000181	0.00184	CcSEcCtD
Norepinephrine—Arrhythmia—Gemcitabine—hematologic cancer	0.000181	0.00184	CcSEcCtD
Norepinephrine—Vomiting—Teniposide—hematologic cancer	0.000179	0.00183	CcSEcCtD
Norepinephrine—Epinephrine—SLC22A1—hematologic cancer	0.000179	0.0582	CrCbGaD
Norepinephrine—Anxiety—Thiotepa—hematologic cancer	0.000178	0.00181	CcSEcCtD
Norepinephrine—Dyspnoea—Lenalidomide—hematologic cancer	0.000178	0.00181	CcSEcCtD
Norepinephrine—Hyperhidrosis—Bortezomib—hematologic cancer	0.000177	0.0018	CcSEcCtD
Norepinephrine—Headache—Teniposide—hematologic cancer	0.000177	0.0018	CcSEcCtD
Norepinephrine—Dyspnoea—Hydroxyurea—hematologic cancer	0.000175	0.00178	CcSEcCtD
Norepinephrine—Hypertension—Thalidomide—hematologic cancer	0.000175	0.00178	CcSEcCtD
Norepinephrine—Bradycardia—Prednisolone—hematologic cancer	0.000173	0.00177	CcSEcCtD
Norepinephrine—Chest pain—Thalidomide—hematologic cancer	0.000172	0.00176	CcSEcCtD
Norepinephrine—Anxiety—Thalidomide—hematologic cancer	0.000172	0.00175	CcSEcCtD
Norepinephrine—Arrhythmia—Cisplatin—hematologic cancer	0.000168	0.00172	CcSEcCtD
Norepinephrine—Hypertension—Carmustine—hematologic cancer	0.000168	0.00171	CcSEcCtD
Norepinephrine—Hypertension—Alitretinoin—hematologic cancer	0.000166	0.00169	CcSEcCtD
Norepinephrine—Vomiting—Busulfan—hematologic cancer	0.000166	0.00169	CcSEcCtD
Norepinephrine—Chest pain—Carmustine—hematologic cancer	0.000166	0.00169	CcSEcCtD
Norepinephrine—Anxiety—Carmustine—hematologic cancer	0.000165	0.00168	CcSEcCtD
Norepinephrine—Hypertension—Ifosfamide—hematologic cancer	0.000164	0.00167	CcSEcCtD
Norepinephrine—Chest pain—Alitretinoin—hematologic cancer	0.000164	0.00167	CcSEcCtD
Norepinephrine—Headache—Busulfan—hematologic cancer	0.000164	0.00167	CcSEcCtD
Norepinephrine—Anxiety—Alitretinoin—hematologic cancer	0.000163	0.00166	CcSEcCtD
Norepinephrine—Dyspnoea—Bortezomib—hematologic cancer	0.000163	0.00166	CcSEcCtD
Norepinephrine—Dyspnoea—Bleomycin—hematologic cancer	0.000162	0.00165	CcSEcCtD
Norepinephrine—Chest pain—Ifosfamide—hematologic cancer	0.000162	0.00165	CcSEcCtD
Norepinephrine—Vomiting—Procarbazine—hematologic cancer	0.000161	0.00164	CcSEcCtD
Norepinephrine—Hypertension—Vincristine—hematologic cancer	0.00016	0.00163	CcSEcCtD
Norepinephrine—Hyperhidrosis—Thalidomide—hematologic cancer	0.00016	0.00163	CcSEcCtD
Norepinephrine—Bradycardia—Triamcinolone—hematologic cancer	0.00016	0.00162	CcSEcCtD
Norepinephrine—Dyspnoea—Vinorelbine—hematologic cancer	0.00016	0.00162	CcSEcCtD
Norepinephrine—ADRA2A—lymph node—hematologic cancer	0.000159	0.00881	CbGeAlD
Norepinephrine—Headache—Procarbazine—hematologic cancer	0.000159	0.00162	CcSEcCtD
Norepinephrine—Vomiting—Dasatinib—hematologic cancer	0.000158	0.00161	CcSEcCtD
Norepinephrine—Vomiting—Bexarotene—hematologic cancer	0.000158	0.00161	CcSEcCtD
Norepinephrine—Vomiting—Fludarabine—hematologic cancer	0.000158	0.00161	CcSEcCtD
Norepinephrine—Hypertension—Mitoxantrone—hematologic cancer	0.000156	0.00159	CcSEcCtD
Norepinephrine—Hypertension—Irinotecan—hematologic cancer	0.000156	0.00159	CcSEcCtD
Norepinephrine—Headache—Dasatinib—hematologic cancer	0.000156	0.00159	CcSEcCtD
Norepinephrine—Headache—Bexarotene—hematologic cancer	0.000156	0.00159	CcSEcCtD
Norepinephrine—Headache—Fludarabine—hematologic cancer	0.000155	0.00158	CcSEcCtD
Norepinephrine—Chest pain—Mitoxantrone—hematologic cancer	0.000154	0.00157	CcSEcCtD
Norepinephrine—Anxiety—Mitoxantrone—hematologic cancer	0.000153	0.00156	CcSEcCtD
Norepinephrine—Arrhythmia—Prednisolone—hematologic cancer	0.000152	0.00155	CcSEcCtD
Norepinephrine—Hypertension—Gemcitabine—hematologic cancer	0.000152	0.00155	CcSEcCtD
Norepinephrine—Hyperhidrosis—Alitretinoin—hematologic cancer	0.000152	0.00155	CcSEcCtD
Norepinephrine—Hyperhidrosis—Ifosfamide—hematologic cancer	0.00015	0.00153	CcSEcCtD
Norepinephrine—Chest pain—Gemcitabine—hematologic cancer	0.00015	0.00153	CcSEcCtD
Norepinephrine—Vomiting—Chlorambucil—hematologic cancer	0.000149	0.00152	CcSEcCtD
Norepinephrine—Dyspnoea—Thalidomide—hematologic cancer	0.000147	0.0015	CcSEcCtD
Norepinephrine—Hyperhidrosis—Vincristine—hematologic cancer	0.000146	0.00149	CcSEcCtD
Norepinephrine—Vomiting—Nilotinib—hematologic cancer	0.000146	0.00149	CcSEcCtD
Norepinephrine—Vomiting—Imatinib—hematologic cancer	0.000145	0.00148	CcSEcCtD
Norepinephrine—Bradycardia—Dexamethasone—hematologic cancer	0.000145	0.00147	CcSEcCtD
Norepinephrine—Bradycardia—Betamethasone—hematologic cancer	0.000145	0.00147	CcSEcCtD
Norepinephrine—Headache—Nilotinib—hematologic cancer	0.000144	0.00147	CcSEcCtD
Norepinephrine—Headache—Imatinib—hematologic cancer	0.000143	0.00146	CcSEcCtD
Norepinephrine—Vomiting—Cladribine—hematologic cancer	0.000143	0.00145	CcSEcCtD
Norepinephrine—Hyperhidrosis—Irinotecan—hematologic cancer	0.000143	0.00145	CcSEcCtD
Norepinephrine—Hyperhidrosis—Mitoxantrone—hematologic cancer	0.000143	0.00145	CcSEcCtD
Norepinephrine—Dyspnoea—Carmustine—hematologic cancer	0.000142	0.00144	CcSEcCtD
Norepinephrine—Headache—Cladribine—hematologic cancer	0.000141	0.00143	CcSEcCtD
Norepinephrine—Dyspnoea—Alitretinoin—hematologic cancer	0.00014	0.00143	CcSEcCtD
Norepinephrine—Arrhythmia—Triamcinolone—hematologic cancer	0.00014	0.00143	CcSEcCtD
Norepinephrine—Anxiety—Cisplatin—hematologic cancer	0.000139	0.00142	CcSEcCtD
Norepinephrine—Hyperhidrosis—Gemcitabine—hematologic cancer	0.000139	0.00142	CcSEcCtD
Norepinephrine—Dyspnoea—Ifosfamide—hematologic cancer	0.000139	0.00141	CcSEcCtD
Norepinephrine—Vomiting—Vinblastine—hematologic cancer	0.000137	0.00139	CcSEcCtD
Norepinephrine—Headache—Vinblastine—hematologic cancer	0.000135	0.00137	CcSEcCtD
Norepinephrine—Dyspnoea—Irinotecan—hematologic cancer	0.000132	0.00134	CcSEcCtD
Norepinephrine—Dyspnoea—Mitoxantrone—hematologic cancer	0.000132	0.00134	CcSEcCtD
Norepinephrine—Vomiting—Melphalan—hematologic cancer	0.00013	0.00133	CcSEcCtD
Norepinephrine—Hypertension—Etoposide—hematologic cancer	0.00013	0.00132	CcSEcCtD
Norepinephrine—Hyperhidrosis—Cisplatin—hematologic cancer	0.00013	0.00132	CcSEcCtD
Norepinephrine—Epinephrine—TNF—hematologic cancer	0.000129	0.0419	CrCbGaD
Norepinephrine—Dyspnoea—Gemcitabine—hematologic cancer	0.000128	0.00131	CcSEcCtD
Norepinephrine—Hypertension—Prednisolone—hematologic cancer	0.000128	0.0013	CcSEcCtD
Norepinephrine—Chest pain—Etoposide—hematologic cancer	0.000128	0.0013	CcSEcCtD
Norepinephrine—Arrhythmia—Betamethasone—hematologic cancer	0.000127	0.00129	CcSEcCtD
Norepinephrine—Arrhythmia—Dexamethasone—hematologic cancer	0.000127	0.00129	CcSEcCtD
Norepinephrine—Vomiting—Lenalidomide—hematologic cancer	0.000127	0.00129	CcSEcCtD
Norepinephrine—Bradycardia—Prednisone—hematologic cancer	0.000126	0.00128	CcSEcCtD
Norepinephrine—Vomiting—Hydroxyurea—hematologic cancer	0.000125	0.00127	CcSEcCtD
Norepinephrine—Headache—Lenalidomide—hematologic cancer	0.000125	0.00127	CcSEcCtD
Norepinephrine—Headache—Hydroxyurea—hematologic cancer	0.000123	0.00125	CcSEcCtD
Norepinephrine—Dyspnoea—Cisplatin—hematologic cancer	0.000119	0.00122	CcSEcCtD
Norepinephrine—Hyperhidrosis—Etoposide—hematologic cancer	0.000119	0.00121	CcSEcCtD
Norepinephrine—Hypertension—Triamcinolone—hematologic cancer	0.000118	0.0012	CcSEcCtD
Norepinephrine—Hyperhidrosis—Prednisolone—hematologic cancer	0.000117	0.00119	CcSEcCtD
Norepinephrine—Vomiting—Bortezomib—hematologic cancer	0.000117	0.00119	CcSEcCtD
Norepinephrine—Vomiting—Bleomycin—hematologic cancer	0.000116	0.00118	CcSEcCtD
Norepinephrine—Headache—Bortezomib—hematologic cancer	0.000115	0.00117	CcSEcCtD
Norepinephrine—Vomiting—Vinorelbine—hematologic cancer	0.000114	0.00116	CcSEcCtD
Norepinephrine—Headache—Vinorelbine—hematologic cancer	0.000112	0.00114	CcSEcCtD
Norepinephrine—Arrhythmia—Prednisone—hematologic cancer	0.000111	0.00113	CcSEcCtD
Norepinephrine—Sweating—Methotrexate—hematologic cancer	0.000111	0.00113	CcSEcCtD
Norepinephrine—Dyspnoea—Etoposide—hematologic cancer	0.000109	0.00111	CcSEcCtD
Norepinephrine—Vomiting—Thiotepa—hematologic cancer	0.000109	0.00111	CcSEcCtD
Norepinephrine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000108	0.0011	CcSEcCtD
Norepinephrine—Headache—Thiotepa—hematologic cancer	0.000107	0.00109	CcSEcCtD
Norepinephrine—Hypertension—Betamethasone—hematologic cancer	0.000107	0.00109	CcSEcCtD
Norepinephrine—Hypertension—Dexamethasone—hematologic cancer	0.000107	0.00109	CcSEcCtD
Norepinephrine—Vomiting—Thalidomide—hematologic cancer	0.000105	0.00107	CcSEcCtD
Norepinephrine—Anxiety—Dexamethasone—hematologic cancer	0.000105	0.00107	CcSEcCtD
Norepinephrine—Anxiety—Betamethasone—hematologic cancer	0.000105	0.00107	CcSEcCtD
Norepinephrine—Headache—Thalidomide—hematologic cancer	0.000104	0.00105	CcSEcCtD
Norepinephrine—Sweating—Epirubicin—hematologic cancer	0.000103	0.00105	CcSEcCtD
Norepinephrine—Vomiting—Carmustine—hematologic cancer	0.000101	0.00103	CcSEcCtD
Norepinephrine—Vomiting—Alitretinoin—hematologic cancer	0.0001	0.00102	CcSEcCtD
Norepinephrine—Headache—Carmustine—hematologic cancer	9.94e-05	0.00101	CcSEcCtD
Norepinephrine—Dyspnoea—Triamcinolone—hematologic cancer	9.93e-05	0.00101	CcSEcCtD
Norepinephrine—Vomiting—Ifosfamide—hematologic cancer	9.88e-05	0.00101	CcSEcCtD
Norepinephrine—Bradycardia—Epirubicin—hematologic cancer	9.86e-05	0.001	CcSEcCtD
Norepinephrine—Headache—Alitretinoin—hematologic cancer	9.85e-05	0.001	CcSEcCtD
Norepinephrine—Hyperhidrosis—Betamethasone—hematologic cancer	9.77e-05	0.000995	CcSEcCtD
Norepinephrine—Hyperhidrosis—Dexamethasone—hematologic cancer	9.77e-05	0.000995	CcSEcCtD
Norepinephrine—Vomiting—Vincristine—hematologic cancer	9.64e-05	0.000981	CcSEcCtD
Norepinephrine—Sweating—Doxorubicin—hematologic cancer	9.57e-05	0.000975	CcSEcCtD
Norepinephrine—Headache—Vincristine—hematologic cancer	9.49e-05	0.000967	CcSEcCtD
Norepinephrine—Vomiting—Mitoxantrone—hematologic cancer	9.38e-05	0.000956	CcSEcCtD
Norepinephrine—Vomiting—Irinotecan—hematologic cancer	9.38e-05	0.000956	CcSEcCtD
Norepinephrine—Hypertension—Prednisone—hematologic cancer	9.31e-05	0.000948	CcSEcCtD
Norepinephrine—Headache—Mitoxantrone—hematologic cancer	9.25e-05	0.000942	CcSEcCtD
Norepinephrine—Headache—Irinotecan—hematologic cancer	9.25e-05	0.000942	CcSEcCtD
Norepinephrine—Anxiety—Prednisone—hematologic cancer	9.15e-05	0.000931	CcSEcCtD
Norepinephrine—Vomiting—Gemcitabine—hematologic cancer	9.14e-05	0.000931	CcSEcCtD
Norepinephrine—Bradycardia—Doxorubicin—hematologic cancer	9.12e-05	0.000929	CcSEcCtD
Norepinephrine—Headache—Gemcitabine—hematologic cancer	9.01e-05	0.000917	CcSEcCtD
Norepinephrine—Arrhythmia—Epirubicin—hematologic cancer	8.65e-05	0.000881	CcSEcCtD
Norepinephrine—Vomiting—Cisplatin—hematologic cancer	8.52e-05	0.000868	CcSEcCtD
Norepinephrine—Hyperhidrosis—Prednisone—hematologic cancer	8.51e-05	0.000866	CcSEcCtD
Norepinephrine—Arrhythmia—Doxorubicin—hematologic cancer	8.01e-05	0.000815	CcSEcCtD
Norepinephrine—Vomiting—Etoposide—hematologic cancer	7.81e-05	0.000795	CcSEcCtD
Norepinephrine—Headache—Etoposide—hematologic cancer	7.69e-05	0.000783	CcSEcCtD
Norepinephrine—Chest pain—Methotrexate—hematologic cancer	7.67e-05	0.000781	CcSEcCtD
Norepinephrine—Headache—Prednisolone—hematologic cancer	7.59e-05	0.000772	CcSEcCtD
Norepinephrine—Hypertension—Epirubicin—hematologic cancer	7.28e-05	0.000741	CcSEcCtD
Norepinephrine—Chest pain—Epirubicin—hematologic cancer	7.18e-05	0.000731	CcSEcCtD
Norepinephrine—Anxiety—Epirubicin—hematologic cancer	7.15e-05	0.000729	CcSEcCtD
Norepinephrine—Hyperhidrosis—Methotrexate—hematologic cancer	7.11e-05	0.000724	CcSEcCtD
Norepinephrine—Vomiting—Triamcinolone—hematologic cancer	7.08e-05	0.000721	CcSEcCtD
Norepinephrine—Headache—Triamcinolone—hematologic cancer	6.98e-05	0.00071	CcSEcCtD
Norepinephrine—Hypertension—Doxorubicin—hematologic cancer	6.74e-05	0.000686	CcSEcCtD
Norepinephrine—Hyperhidrosis—Epirubicin—hematologic cancer	6.65e-05	0.000677	CcSEcCtD
Norepinephrine—Chest pain—Doxorubicin—hematologic cancer	6.64e-05	0.000676	CcSEcCtD
Norepinephrine—Anxiety—Doxorubicin—hematologic cancer	6.62e-05	0.000674	CcSEcCtD
Norepinephrine—Dyspnoea—Methotrexate—hematologic cancer	6.56e-05	0.000668	CcSEcCtD
Norepinephrine—Vomiting—Dexamethasone—hematologic cancer	6.42e-05	0.000654	CcSEcCtD
Norepinephrine—Vomiting—Betamethasone—hematologic cancer	6.42e-05	0.000654	CcSEcCtD
Norepinephrine—Headache—Betamethasone—hematologic cancer	6.33e-05	0.000645	CcSEcCtD
Norepinephrine—Headache—Dexamethasone—hematologic cancer	6.33e-05	0.000645	CcSEcCtD
Norepinephrine—Hyperhidrosis—Doxorubicin—hematologic cancer	6.16e-05	0.000627	CcSEcCtD
Norepinephrine—Dyspnoea—Epirubicin—hematologic cancer	6.13e-05	0.000625	CcSEcCtD
Norepinephrine—Dyspnoea—Doxorubicin—hematologic cancer	5.68e-05	0.000578	CcSEcCtD
Norepinephrine—Vomiting—Prednisone—hematologic cancer	5.59e-05	0.00057	CcSEcCtD
Norepinephrine—Headache—Prednisone—hematologic cancer	5.51e-05	0.000561	CcSEcCtD
Norepinephrine—Vomiting—Methotrexate—hematologic cancer	4.68e-05	0.000476	CcSEcCtD
Norepinephrine—Headache—Methotrexate—hematologic cancer	4.61e-05	0.000469	CcSEcCtD
Norepinephrine—Vomiting—Epirubicin—hematologic cancer	4.38e-05	0.000446	CcSEcCtD
Norepinephrine—Headache—Epirubicin—hematologic cancer	4.31e-05	0.000439	CcSEcCtD
Norepinephrine—Vomiting—Doxorubicin—hematologic cancer	4.05e-05	0.000412	CcSEcCtD
Norepinephrine—Headache—Doxorubicin—hematologic cancer	3.99e-05	0.000406	CcSEcCtD
Norepinephrine—ADRA1A—Signaling Pathways—FGF2—hematologic cancer	1.47e-06	1.4e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCND1—hematologic cancer	1.47e-06	1.39e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—JUN—hematologic cancer	1.46e-06	1.39e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—JAK2—hematologic cancer	1.46e-06	1.39e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—HRAS—hematologic cancer	1.46e-06	1.39e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SRC—hematologic cancer	1.45e-06	1.38e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3R1—hematologic cancer	1.45e-06	1.38e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCND1—hematologic cancer	1.45e-06	1.38e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—EP300—hematologic cancer	1.44e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—JUN—hematologic cancer	1.44e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.44e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.44e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HRAS—hematologic cancer	1.44e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1B—hematologic cancer	1.43e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAP2K1—hematologic cancer	1.43e-06	1.36e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	1.43e-06	1.36e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	1.43e-06	1.36e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PTEN—hematologic cancer	1.43e-06	1.36e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MDM2—hematologic cancer	1.43e-06	1.36e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CD—hematologic cancer	1.42e-06	1.36e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—hematologic cancer	1.42e-06	1.35e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CDKN1A—hematologic cancer	1.42e-06	1.35e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—hematologic cancer	1.41e-06	1.35e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PTEN—hematologic cancer	1.41e-06	1.35e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1B—hematologic cancer	1.41e-06	1.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—hematologic cancer	1.41e-06	1.34e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—JAK2—hematologic cancer	1.41e-06	1.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP3—hematologic cancer	1.41e-06	1.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL2—hematologic cancer	1.4e-06	1.34e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—STAT3—hematologic cancer	1.4e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	1.4e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NRAS—hematologic cancer	1.4e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—hematologic cancer	1.4e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—hematologic cancer	1.4e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	1.4e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PTEN—hematologic cancer	1.4e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—KRAS—hematologic cancer	1.39e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	1.39e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MTOR—hematologic cancer	1.39e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	1.39e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—hematologic cancer	1.39e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP3—hematologic cancer	1.38e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MAPK8—hematologic cancer	1.38e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL2—hematologic cancer	1.38e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—hematologic cancer	1.38e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—PIK3CA—hematologic cancer	1.38e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—hematologic cancer	1.37e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MDM2—hematologic cancer	1.37e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCND1—hematologic cancer	1.37e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	1.37e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—JUN—hematologic cancer	1.37e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—FGF2—hematologic cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EP300—hematologic cancer	1.36e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EP300—hematologic cancer	1.35e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCND1—hematologic cancer	1.35e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3R1—hematologic cancer	1.35e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—JUN—hematologic cancer	1.34e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MAPK3—hematologic cancer	1.34e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MTOR—hematologic cancer	1.34e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CB—hematologic cancer	1.34e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EP300—hematologic cancer	1.33e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HRAS—hematologic cancer	1.32e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1A—hematologic cancer	1.32e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SRC—hematologic cancer	1.32e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PTEN—hematologic cancer	1.32e-06	1.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SRC—hematologic cancer	1.31e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—JAK2—hematologic cancer	1.31e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1A—hematologic cancer	1.3e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	1.3e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MYC—hematologic cancer	1.3e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PTEN—hematologic cancer	1.3e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TGFB1—hematologic cancer	1.3e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SRC—hematologic cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MAPK8—hematologic cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—hematologic cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	1.29e-06	1.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTEN—hematologic cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—PIK3CA—hematologic cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—hematologic cancer	1.28e-06	1.22e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—STAT3—hematologic cancer	1.28e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MDM2—hematologic cancer	1.28e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	1.28e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP3—hematologic cancer	1.28e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL2—hematologic cancer	1.27e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NRAS—hematologic cancer	1.27e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.27e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MAPK8—hematologic cancer	1.27e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—hematologic cancer	1.27e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—hematologic cancer	1.27e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—STAT3—hematologic cancer	1.26e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NRAS—hematologic cancer	1.26e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	1.26e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EP300—hematologic cancer	1.26e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	1.25e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—STAT3—hematologic cancer	1.25e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NRAS—hematologic cancer	1.25e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCND1—hematologic cancer	1.24e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CB—hematologic cancer	1.24e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MTOR—hematologic cancer	1.24e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	1.24e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EP300—hematologic cancer	1.24e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—JUN—hematologic cancer	1.24e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	1.23e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL2—hematologic cancer	1.23e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SRC—hematologic cancer	1.23e-06	1.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—EP300—hematologic cancer	1.22e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	1.22e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	1.22e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MAPK3—hematologic cancer	1.21e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SRC—hematologic cancer	1.21e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—KRAS—hematologic cancer	1.2e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	1.2e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PTEN—hematologic cancer	1.2e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	1.2e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—JUN—hematologic cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—hematologic cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	1.19e-06	1.14e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MYC—hematologic cancer	1.19e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	1.19e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	1.18e-06	1.13e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—STAT3—hematologic cancer	1.18e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NRAS—hematologic cancer	1.18e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MYC—hematologic cancer	1.18e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TGFB1—hematologic cancer	1.17e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	1.17e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	1.17e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	1.16e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MYC—hematologic cancer	1.16e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	1.16e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	1.16e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	1.16e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	1.15e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	1.15e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	1.15e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EP300—hematologic cancer	1.14e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	1.14e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	1.14e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	1.13e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	1.13e-06	1.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MAPK3—hematologic cancer	1.13e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	1.13e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.12e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PIK3CA—hematologic cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SRC—hematologic cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	1.11e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	1.11e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	1.1e-06	1.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MYC—hematologic cancer	1.1e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—KRAS—hematologic cancer	1.1e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TGFB1—hematologic cancer	1.1e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—KRAS—hematologic cancer	1.09e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.08e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	1.08e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	1.08e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	1.08e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	1.07e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—KRAS—hematologic cancer	1.07e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.07e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	1.07e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.07e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.07e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—hematologic cancer	1.07e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.07e-06	1.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	1.05e-06	9.99e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	1.05e-06	9.96e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	1.04e-06	9.93e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	1.03e-06	9.83e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	1.03e-06	9.81e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.02e-06	9.75e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	1.02e-06	9.74e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	1.02e-06	9.73e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—KRAS—hematologic cancer	1.01e-06	9.66e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	1.01e-06	9.58e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	9.98e-07	9.5e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PIK3CA—hematologic cancer	9.98e-07	9.5e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MYC—hematologic cancer	9.96e-07	9.48e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	9.95e-07	9.47e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	9.94e-07	9.46e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CREBBP—hematologic cancer	9.92e-07	9.44e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	9.87e-07	9.39e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	9.85e-07	9.38e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—hematologic cancer	9.78e-07	9.31e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—hematologic cancer	9.74e-07	9.27e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	9.69e-07	9.22e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—hematologic cancer	9.65e-07	9.19e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	9.6e-07	9.13e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	9.6e-07	9.13e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	9.57e-07	9.11e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	9.57e-07	9.11e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—hematologic cancer	9.53e-07	9.07e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	9.4e-07	8.95e-06	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—hematologic cancer	9.36e-07	8.91e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PIK3CA—hematologic cancer	9.32e-07	8.87e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HRAS—hematologic cancer	9.32e-07	8.87e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—hematologic cancer	9.28e-07	8.84e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HRAS—hematologic cancer	9.23e-07	8.79e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—KRAS—hematologic cancer	9.2e-07	8.76e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	9.17e-07	8.73e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	9.17e-07	8.73e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HRAS—hematologic cancer	9.11e-07	8.67e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—hematologic cancer	9.1e-07	8.67e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	9.05e-07	8.62e-06	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	9.03e-07	8.59e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—hematologic cancer	9.02e-07	8.58e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	8.92e-07	8.49e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—hematologic cancer	8.92e-07	8.49e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	8.89e-07	8.47e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	8.88e-07	8.45e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	8.87e-07	8.45e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	8.87e-07	8.44e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—hematologic cancer	8.83e-07	8.41e-06	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—hematologic cancer	8.72e-07	8.3e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—hematologic cancer	8.72e-07	8.3e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HRAS—hematologic cancer	8.62e-07	8.21e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	8.49e-07	8.08e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	8.46e-07	8.05e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—hematologic cancer	8.25e-07	7.85e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	8.24e-07	7.84e-06	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—hematologic cancer	8.22e-07	7.83e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	8.2e-07	7.8e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—hematologic cancer	8.18e-07	7.79e-06	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—hematologic cancer	8.15e-07	7.76e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	8.15e-07	7.75e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	8.12e-07	7.73e-06	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—hematologic cancer	8.05e-07	7.66e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	7.88e-07	7.5e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HRAS—hematologic cancer	7.82e-07	7.45e-06	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—hematologic cancer	7.61e-07	7.25e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	7.57e-07	7.2e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	7.54e-07	7.17e-06	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	7.49e-07	7.13e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—hematologic cancer	7.49e-07	7.13e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—hematologic cancer	7.39e-07	7.04e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	7.32e-07	6.97e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	7.21e-07	6.87e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTEN—hematologic cancer	7.08e-07	6.74e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	7e-07	6.67e-06	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—hematologic cancer	6.91e-07	6.58e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—EP300—hematologic cancer	6.76e-07	6.43e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	6.7e-07	6.38e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	6.65e-07	6.33e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	6.18e-07	5.89e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	5e-07	4.76e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—hematologic cancer	4.08e-07	3.89e-06	CbGpPWpGaD
